Sales & Marketing
12 Questions with Kevin Asher, Acumetis
Sponsored

12 Questions with Kevin Asher

Kevin Asher leads Acumetis's Medical Practice, bringing 15+ years in Medical Affairs to teams across the industry.

Oncology
Jonah Comstock and Thanos Zomas at ASCO 2024

ASCO 2024 – Thanos Zomas

Great advances in cancer care have led to a new phase of research in certain cancers – in areas where a high rate of cure has been established, the focus is shifting to quality of life, sid

Sales & Marketing
the power of GenAI

Power launch excellence with generative AI

As debate about the usefulness and ethics of generative artificial intelligence (AI) continues, the pharmaceutical industry needs to consider the advantages it can offer, especially for inc

Sales & Marketing

Sales & Marketing
12 Questions with Kevin Asher, Acumetis
Sponsored

12 Questions with Kevin Asher

Kevin Asher leads Acumetis's Medical Practice, bringing 15+ years in Medical Affairs to teams across the industry.

Digital

Market Access

Editor's Picks

  1. Vertex buys Crinetics for $10bn in endocrinology drive
  2. UK first in Europe to clear Boehringer's IPF drug Jascayd
  3. NICE aims to cut funding for Amgen lung cancer drug Lumykras
  4. Island Pharma drug cleared for Bundibugyo Ebola use
  5. NICE backs NHS use of non-invasive endometriosis tests

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more